Searched for
NIVA BUPA HEALTHCARE GROWTH CAGR
Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- MF Tracker: How Edelweiss Large Cap Fund logged positive returns in last 10 calendar yearsEdelweiss Large Cap Fund has achieved a remarkable decade of positive returns, never dipping into negative territory. This consistency is a...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Tata Motors shares jump 5% on strong growth guidance. What are Nomura, other brokerages saying?Tata Motors shares rose after outlining strong growth targets, including margin expansion and cash flow improvement. Brokerages remain divi...
- India's textile industry poised for long-term growth as global sourcing shift gathers pace: Siddhartha KhemkaIndia's textile sector is poised for significant growth, driven by a global shift in sourcing away from China and a cyclical recovery in de...
- Motilal Oswal initiates coverage on KPR Mill, 7 other textile stocks with up to 43% upside. Own any?Motilal Oswal has initiated coverage on eight textile companies, turning bullish on Gokaldas Exports, Indo Count, Arvind Fashions, Pearl Gl...
- The Adani stock Morgan Stanley thinks could benefit most from India’s infrastructure pushMorgan Stanley has initiated coverage on Adani Enterprises with an Overweight rating and a target price of Rs 3,638, implying a 23% upside....
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Jefferies initiates coverage on GE Vernova, bullish on 2 other power transmission stocksJefferies has initiated coverage on GE Vernova T&D India with a Hold rating and a target price of ₹6,000, citing limited upside despite str...
- Buy, Sell or Hold: Citi initiates buy on Meesho; Elara Capital recommends buy on Mahindra LogisticsBrokerages are selectively backing consumer, logistics, and e-commerce firms with strong growth prospects. Citi initiates coverage on Meesh...
- India to witness rapid data centre growth fueled by favourable demographics: Goldman SachsThe report, titled Outlook for Data Centers in Asia, states that data centre demand is expected to grow at a 20% compound annual growth rat...
- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- Betting on India’s travel boom? Motilal Oswal sees TBO Tek and Ixigo as key beneficiariesThe industry has evolved significantly over the past two decades—from a fragmented, offline agent-driven market to a digitally enabled ecos...
- Foreign whisky sales slow for second straight year as post-pandemic boom fadesGrowth in imported whisky sales slowed for a second consecutive year in 2025 across Scotch, Irish, Japanese and American categories, reflec...
- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- Coforge shares jump over 2% as firm eyes $5 billion revenue by FY30. Why Nomura, others see up to 50% upside?Coforge shares saw a rise after the company projected $5 billion in revenue by FY30. This ambitious target is fueled by strong organic grow...
- Nomura raises Adani Ports share price target by 12%. Here are 3 major reasons whyNomura has raised its target price on Adani Ports and Special Economic Zone to Rs 2,080 from Rs 1,850, while retaining its Buy rating. The ...
- India's telecom ARPU to grow 7% CAGR through FY29; narrowing tariff gap with global markets: ReportIndia's telecom sector is set for a multi-year growth phase. Average Revenue Per User (ARPU) is projected to grow at 7% annually from FY26 ...
- Global firms exploit India's IPO boom to take profits back to home countriesForeign companies are listing their Indian units to send billions of dollars back home. These are mostly secondary offerings, not for raisi...
Load More
